CLINICAL

11 of the Weirdest Medical Facts Ever Believed
11 of the Weirdest Medical Facts Ever BelievedFrom the Drug Topics archives, one of most popular features in our history returns.
Colorscience introduces Clinical Redness CorrectorAll Calm™ Clinical Redness Corrector is formulated for redness, rosacea and sensitive skin, according to the company.
Manuka honey tested as AD treatmentA pilot study shows that Manuka honey may have some healing properties in atopic dermatitis.
An AD treatment phobia that is a “phenomenon”Atopic dermatitis patients have a phobia of topical corticosteroids that is so strong, it’s been described as a “phenomenon.”
Atopic dermatitis phenotypes may indicate outcomesChildren under two years old with signs of atopic dermatitis have an increased risk of developing asthma and food allergies, researchers report in JAMA Pediatrics. And, young children with both early onset atopic dermatitis and a food allergy, have a “very high risk” of developing asthma or allergic rhinitis.
Patch testing remains underreported
Patch testing remains underreportedPatch testing for allergic contact dermatitis in the pediatric population is performed at a higher rate than previously reported, but still grossly underreported, according to a study of the Pediatric Contact Dermatitis Registry.
Antimicrobials approved for children’s skin infectionsFor the first time in a decade, there are antibiotics newly approved for use in children with skin and skin structure infections that do not respond to conventional treatment.
Treatment updates for atopic dermatitis in childrenBecause the burden of atopic dermatitis in children is significant and can adversely impact a child’s normal socialization development, accurate diagnosis and effective treatment are vital.
Oral baricitinib instead of topicals for atopic dermatitis?EADV study shows that this JAK inhibitor is a promising drug candidate in moderate-to-severe AD.
Guselkumab front and center at EADV Congress
Guselkumab front and center at EADV CongressIL-23 inhibitors represent one more very effective strategy for controlling psoriasis with PASI rates comparable to other biologics.

Poll

View Results